Physician profile
Ashesh S Dave
NPI 1871536706
$974.59
in general payments reported to CMS, 2019-2025
12 companies · $29.24 in 2025
The $29.24 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $64.15 · 2021: $339 · 2022: $259 · 2023: $60.27 · 2024: $36.30 · 2025: $29.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $339.47 | 2020-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $174.41 | 2019-2022 | |
| Lilly USA, LLC | $116.06 | 2019-2022 | |
| Novo Nordisk INC | $71.72 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.39 | 2019-2022 | |
| Amgen INC. | $55.94 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $46.37 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $26.78 | 2021-2022 | |
| Althera Pharmaceuticals LLC | $24.92 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.95 | 2022 | |
| Janssen Pharmaceuticals, INC | $20.50 | 2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashesh Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.